Status:
TERMINATED
A Clinical Data Collection Study of Verily Patch
Lead Sponsor:
Verily Life Sciences LLC
Conditions:
Febrile
Afebrile
Eligibility:
All Genders
18+ years
Brief Summary
This is a single center, prospective, non-randomized prospective observational data collection study of the Verily Patch. The Verily Patch is an investigational wearable, continuous temperature sensor...
Eligibility Criteria
Inclusion
- At least 18 years old
- Able to read and speak English
- Able to read and understand the Informed Consent Form
- Willing to wear Verily Patch in the axillary region
- Willing to comply with repeated self-measurement of oral and axillary temperatures and willing to record temperature readings
- Have a working smartphone device and willing to use it for study activities
- Willing to install study apps on their personal smartphone
- Willing to comply with all study-related procedures
Exclusion
- Pregnant or breastfeeding during study participation
- Have known allergies to medical grade adhesives
- Have known cutaneous hypersensitivity
- Have infection in both axilla
- Have open injury or rash where the study device will be worn
- Have a cardiac pacemaker or other implanted electronic medical device(s)
- Have any additional condition or situation that, in the opinion of the investigator, makes the subject inappropriate for participation in the study
Key Trial Info
Start Date :
March 11 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 25 2021
Estimated Enrollment :
22 Patients enrolled
Trial Details
Trial ID
NCT04727801
Start Date
March 11 2021
End Date
May 25 2021
Last Update
August 20 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UT Southwestern Medical Center
Dallas, Texas, United States, 75390